DENTSPLY Sirona Inc. (XRAY) recently announced the completion of the merger between DENTSPLY International and Sirona Dental Systems.
DENTSPLY International Inc. (XRAY) reported adjusted earnings of 65 cents per share in the fourth quarter of 2015, in line with the Zacks Consensus Estimate.
DENTSPLY International reports fourth quarter 2015 earnings results.
DENTSPLY International, Inc. (XRAY) is set to report fourth-quarter 2015 earnings results on Feb 12.
Boston Scientific Corporation (BSX) is scheduled to report its fourth-quarter 2015 results before the opening bell on Feb 4, 2016.
On Dec 28, 2015, we issued an updated research report on California-based Align Technology Inc. (ALGN).
Laboratory Corp. of America Holdings (LH) recently agreed to purchase all the operating assets of full-service independent women's health laboratory Pathology, Inc.
On Dec 5, Zacks Investment Research downgraded The Cooper Companies Inc (COO) to a Zacks Rank #5 (Strong Sell).
Shares of DENTSPLY International Inc. (XRAY) rallied to a new 52-week high of $62.79 on Dec 3.
On Nov 30, 2015, we issued an updated research report on California-based Align Technology Inc. (ALGN).
DENTSPLY International Inc. (XRAY) and Sirona Dental Systems (SIRO) recently announced the expiration of the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976.
Patterson Companies (PDCO) is set to report second-quarter fiscal 2016 earnings results on Nov 24.
Becton, Dickinson and Company (BDX) reported fourth-quarter fiscal 2015 earnings of $1.94 per share, which beat the Zacks Consensus Estimate by four cents.
DENTSPLY International (XRAY) reported adjusted earnings of 66 cents per share (EPS) in the third quarter of 2015, beating the Zacks Consensus Estimate of 63 cents and also improving 6.5% on a year-over-year basis.
DENTSPLY International Inc. (XRAY) is set to report third-quarter 2015 results on Oct 28.
On Sep 25, 2015, we issued an updated research report on Laboratory Corporation of America Holdings (LH).
Align Technology (ALGN) delivered an impressive performance in the second quarter of 2015. However, on a year-over-year basis, earnings faltered.